Income Statement
KYNTRA BIO, INC.
KYNB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
218.60 | 159.00 | 147.75 | 140.73 | 235.31 | 176.32 | 256.58 | 212.96 | 125.67 | 179.58 | 180.83 |
|
Cost of Revenue
|
0.56 | 15.56 | 18.85 | 20.28 | 12.87 | - | - | - | - | - | - |
|
Gross Profit
|
218.04 | 143.44 | 128.90 | 120.45 | 222.44 | 176.32 | 256.58 | 212.96 | 125.67 | 179.58 | 180.83 |
|
Operating Expenses
|
51.23 | 145.02 | 398.11 | 421.48 | 510.97 | 368.20 | 345.89 | 299.65 | 248.28 | 233.23 | 258.45 |
|
Research & Development
|
23.52 | 95.69 | 282.86 | 296.79 | 387.04 | 252.92 | 209.27 | 235.84 | 196.52 | 187.21 | 214.09 |
|
Selling, General & Administrative
|
27.71 | 49.33 | 115.25 | 124.69 | 123.93 | 106.41 | 135.48 | 63.81 | 51.76 | 46.03 | 44.36 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
166.82 | -1.58 | -269.21 | -301.03 | -288.53 | -191.88 | -89.31 | -86.69 | -122.61 | -53.65 | -77.63 |
|
Non-Operating Income
|
2.94 | 5.30 | 10.48 | 7.60 | -1.08 | -2.95 | -12.67 | -0.58 | 3.27 | 8.10 | 7.91 |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
8.76 | 11.70 | 15.53 | 1.44 | 1.08 | 2.40 | 2.88 | 10.99 | 9.71 | 10.73 | 11.03 |
|
Other Non-Op Income / Expense
|
2.50 | 4.00 | 2.64 | 1.60 | 1.01 | 0.20 | - | - | - | - | - |
|
Income Before Tax
|
-58.29 | -153.37 | -286.87 | -294.87 | -290.68 | -188.93 | -76.64 | -86.12 | -125.88 | -61.75 | -85.54 |
|
Income Tax Expense
|
-58.29 | -153.37 | -286.87 | -294.87 | -290.68 | -188.93 | -76.64 | -86.12 | -125.88 | -61.75 | -85.54 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
166.82 | -1.58 | -269.21 | -301.03 | -288.53 | -191.88 | -89.31 | -86.69 | -122.61 | -53.65 | -77.63 |
|
Earnings Per Share (Basic)
|
45.37 | -0.48 | -2.92 | -3.14 | - | - | - | - | - | - | - |
|
Diluted EPS
|
45.37 | -0.48 | -2.92 | -3.14 | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
4.04 | 100.04 | 97.30 | 93.58 | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
4.04 | 100.04 | 97.30 | 93.58 | - | - | - | - | - | - | - |
|
Comprehensive Income
|
187.00 | -46.44 | -285.39 | -295.21 | -289.69 | -193.04 | -76.05 | -85.66 | -127.04 | -60.99 | -84.28 |